Improvement in Health-Related Quality of Life for Sickle Cell Disease Patients Treated With Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation: A Pilot Study
Value in Health - United Kingdom
doi 10.1016/j.jval.2015.03.1758
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV